135 related articles for article (PubMed ID: 16627469)
1. Inhibition of the mitotic kinesin Eg5 up-regulates Hsp70 through the phosphatidylinositol 3-kinase/Akt pathway in multiple myeloma cells.
Liu M; Aneja R; Liu C; Sun L; Gao J; Wang H; Dong JT; Sarli V; Giannis A; Joshi HC; Zhou J
J Biol Chem; 2006 Jun; 281(26):18090-7. PubMed ID: 16627469
[TBL] [Abstract][Full Text] [Related]
2. HSP70 regulates Eg5 distribution within the mitotic spindle and modulates the cytotoxicity of Eg5 inhibitors.
Fang CT; Kuo HH; Hsu SC; Yih LH
Cell Death Dis; 2020 Sep; 11(8):715. PubMed ID: 32873777
[TBL] [Abstract][Full Text] [Related]
3. The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma.
Chatterjee M; Andrulis M; Stühmer T; Müller E; Hofmann C; Steinbrunn T; Heimberger T; Schraud H; Kressmann S; Einsele H; Bargou RC
Haematologica; 2013 Jul; 98(7):1132-41. PubMed ID: 23065523
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
Chin GM; Herbst R
Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103
[TBL] [Abstract][Full Text] [Related]
5. Parkin regulates Eg5 expression by Hsp70 ubiquitination-dependent inactivation of c-Jun NH2-terminal kinase.
Liu M; Aneja R; Sun X; Xie S; Wang H; Wu X; Dong JT; Li M; Joshi HC; Zhou J
J Biol Chem; 2008 Dec; 283(51):35783-8. PubMed ID: 18845538
[TBL] [Abstract][Full Text] [Related]
6. Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor cells treated with the kinesin spindle protein inhibitor ARRY-520.
Tunquist BJ; Woessner RD; Walker DH
Mol Cancer Ther; 2010 Jul; 9(7):2046-56. PubMed ID: 20571074
[TBL] [Abstract][Full Text] [Related]
7. De-repression of heat shock transcription factor-1 in interleukin-6- treated hepatocytes is mediated by downregulation of glycogen synthase kinase 3beta and MAPK/ERK-1.
Wigmore SJ; Sangster K; McNally SJ; Harrison EM; Ross JA; Fearon KC; Garden OJ
Int J Mol Med; 2007 Mar; 19(3):413-20. PubMed ID: 17273789
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.
Shi Y; Yan H; Frost P; Gera J; Lichtenstein A
Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402
[TBL] [Abstract][Full Text] [Related]
9. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation.
Zhou J; Schmid T; Frank R; Brüne B
J Biol Chem; 2004 Apr; 279(14):13506-13. PubMed ID: 14726529
[TBL] [Abstract][Full Text] [Related]
10. The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma.
Wang L; Lin N; Li Y
Oncol Rep; 2019 Mar; 41(3):1678-1690. PubMed ID: 30664164
[TBL] [Abstract][Full Text] [Related]
11. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling.
Ivanov VN; Krasilnikov M; Ronai Z
J Biol Chem; 2002 Feb; 277(7):4932-44. PubMed ID: 11733515
[TBL] [Abstract][Full Text] [Related]
14. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression.
Skoufias DA; DeBonis S; Saoudi Y; Lebeau L; Crevel I; Cross R; Wade RH; Hackney D; Kozielski F
J Biol Chem; 2006 Jun; 281(26):17559-69. PubMed ID: 16507573
[TBL] [Abstract][Full Text] [Related]
15. TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells.
Ramakrishnan V; Kimlinger T; Haug J; Timm M; Wellik L; Halling T; Pardanani A; Tefferi A; Rajkumar SV; Kumar S
Am J Hematol; 2010 Sep; 85(9):675-86. PubMed ID: 20652971
[TBL] [Abstract][Full Text] [Related]
16. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
[TBL] [Abstract][Full Text] [Related]
17. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells.
Panka DJ; Mano T; Suhara T; Walsh K; Mier JW
J Biol Chem; 2001 Mar; 276(10):6893-6. PubMed ID: 11145953
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts.
Yamane K; Ihn H; Tamaki K
Arthritis Rheum; 2003 Jun; 48(6):1652-66. PubMed ID: 12794834
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed Hsp70 alleviated formaldehyde-induced apoptosis partly via PI3K/Akt signaling pathway in human bronchial epithelial cells.
Liu L; Huang Y; Feng X; Chen J; Duan Y
Environ Toxicol; 2019 Apr; 34(4):495-504. PubMed ID: 30600586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
